142 related articles for article (PubMed ID: 28612620)
1. SAMPUS, MELTUMP and THIMUMP - Diagnostic Categories Characterized by Uncertain Biological Behavior.
Roncati L; Piscioli F; Pusiol T
Klin Onkol; 2017; 30(3):221-223. PubMed ID: 28612620
[TBL] [Abstract][Full Text] [Related]
2. Theory and practical application of superficial atypical melanocytic proliferations of uncertain significance (SAMPUS) and melanocytic tumours of uncertain malignant potential (MELTUMP) terminology: experience with second opinion consultation.
Pusiol T; Morichetti D; Piscioli F; Zorzi MG
Pathologica; 2012 Apr; 104(2):70-7. PubMed ID: 22953503
[TBL] [Abstract][Full Text] [Related]
3. Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J; Doeleman T; van Doorn R; Mooyaart AL; Blokx WAM; Schrader AMR
J Am Acad Dermatol; 2023 Mar; 88(3):602-608. PubMed ID: 36403750
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP).
Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L
Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902
[TBL] [Abstract][Full Text] [Related]
5. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
6. MELTUMP: how to manage these lesions in the clinical routine.
Piccolo V; Moscarella E; Lallas A; Alfano R; Ferrara G; Argenziano G
G Ital Dermatol Venereol; 2017 Jun; 152(3):266-269. PubMed ID: 28195450
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of the Complex Melanoma Pathology Report.
Crompton JG; Busam KJ; Bartlett EK
Surg Oncol Clin N Am; 2020 Jul; 29(3):327-338. PubMed ID: 32482311
[TBL] [Abstract][Full Text] [Related]
8. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.
J Clin Pathol; 1997 Mar; 50(3):202-5. PubMed ID: 9155669
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Disputes Regarding Atypical Melanocytic Lesions can be Solved by Using the Term MELTUMP.
Piscioli F; Pusiol T; Roncati L
Turk Patoloji Derg; 2016; 32(1):63-4. PubMed ID: 26832185
[No Abstract] [Full Text] [Related]
10. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
11. "Lentiginous melanoma": full-fledged melanoma or melanoma precursor?
Mooi WJ
Adv Anat Pathol; 2014 May; 21(3):181-7. PubMed ID: 24713988
[TBL] [Abstract][Full Text] [Related]
12. Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia.
Reed RJ
Clin Lab Med; 2000 Dec; 20(4):745-58. PubMed ID: 11221513
[TBL] [Abstract][Full Text] [Related]
13. Highlighting the immunohistochemical profile of melanocytomas: review.
Quatresooz P; Piérard-Franchimont C; Piérard GE
Oncol Rep; 2008 Jun; 19(6):1367-72. PubMed ID: 18497938
[TBL] [Abstract][Full Text] [Related]
14. Increased diagnosis of thin superficial spreading melanomas: A 20-year study.
Frangos JE; Duncan LM; Piris A; Nazarian RM; Mihm MC; Hoang MP; Gleason B; Flotte TJ; Byers HR; Barnhill RL; Kimball AB
J Am Acad Dermatol; 2012 Sep; 67(3):387-94. PubMed ID: 22153791
[TBL] [Abstract][Full Text] [Related]
15. Borderline and atypical melanocytic lesions.
Brodell RT; Santa Cruz DJ
Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
[TBL] [Abstract][Full Text] [Related]
16. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?
Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M
Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231
[TBL] [Abstract][Full Text] [Related]
17. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel.
Cook MG; Clarke TJ; Humphreys S; Fletcher A; McLaren KM; Smith NP; Stevens A; Theaker JM; Melia J
Histopathology; 1996 Jun; 28(6):497-512. PubMed ID: 8803593
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review.
Kwittken J
J Med; 1991; 22(1):1-16. PubMed ID: 2072047
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
